The mean HbA1c reductions from baseline were 2.01% with 5 mg, 2.24% with 10 mg, and 2.30% with 15 mg of tirzepatide, compared with 1.86% for semaglutide
Verify the current threshold on the Blue Shield of CA formulary, as policies can change
Among those who have taken GLP-1s, the most common reasons for doing so are to lose weight (70 percent), manage Type 2 diabetes (41 percent), or improve other health conditions such as blood pressure or cholesterol (24 percent)
One explanation for this is what researchers call the set point theory, which suggests that each person has a specific weight range their body naturally tries to maintain
It concluded: "There is a strong indication that GLP-1 receptor agonists may have a useful role in future treatment of Parkinson's disease." Of note, both trials had a washout period after the drug treatment ended and the benefit for motor symptoms persisted
Tumor-derived extracellular vesicles breach the intact blood-brain barrier via transcytosis